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Background: Recombinatorial cloning using the GatewayTM technology has been the method of choice for
high-throughput omics projects, resulting in the availability of entire ORFeomes in GatewayTM compatible vectors.
The MultiSite GatewayTM system allows combining multiple genetic fragments such as promoter, ORF and epitope
tag in one single reaction. To date, this technology has not been accessible in the yeast Saccharomyces cerevisiae,
one of the most widely used experimental systems in molecular biology, due to the lack of appropriate destination
vectors.
Results: Here, we present a set of three-fragment MultiSite GatewayTM destination vectors that have been
developed for gene expression in S. cerevisiae and that allow the assembly of any promoter, open reading frame,
epitope tag arrangement in combination with any of four auxotrophic markers and three distinct replication
mechanisms. As an example of its applicability, we used yeast three-hybrid to provide evidence for the assembly of
a ternary complex of plant proteins involved in jasmonate signalling and consisting of the JAZ, NINJA and TOPLESS
proteins.
Conclusion: Our vectors make MultiSite GatewayTM cloning accessible in S. cerevisiae and implement a fast and
versatile cloning method for the high-throughput functional analysis of (heterologous) proteins in one of the most
widely used model organisms for molecular biology research.
Keywords: Gateway cloning, MultiSite, Saccharomyces cerevisiae, Yeast, Vector, Fusion protein, Epitope tag,
Jasmonate, Arabidopsis thalianaBackground
The model organism Saccharomyces cerevisiae has con-
tributed greatly to our current understanding on
eukaryotic genes, their products, and their functions.
Decades of study have resulted in an extensive know-
ledge on yeast physiology, genetics, and the molecular
functions and interactions of its proteins. Furthermore,
this unicellular eukaryotic system is well suited for the
study of basic cellular processes which are often con-
served in higher eukaryotes. Because of its ease for* Correspondence: algoo@psb.vib-ugent.be
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distribution, and reproduction in any mediumgenetic modification and fast growth, yeast became the
system of choice for in vivo protein analyses from other
eukaryotes. S. cerevisiae was used, for example, to per-
form proteome-wide analysis of the human protein-
protein interaction networks [1], to systematically
analyze protein-DNA interaction networks of the nema-
tode C. elegans [2], and to produce high-value bioactive
plant secondary metabolites through metabolic engineer-
ing approaches [3].
Large scale genomics approaches to uncover protein
function are adopted more and more in the current era
of systems biology research. To cope with the large
amounts of constructs needed, scientists make use of
high-throughput cloning technologies, such as the
GatewayTM technology (Invitrogen; http://www.invitrogen.
com/), which is based on the site-specific recombination
system from the bacteriophage lambda that facilitatesCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Figure 1 Schematic overview of (MultiSite) GatewayTM cloning and properties of the constructed destination vectors. (A) Overview of the
GatewayTM cloning procedure. Attachment of attB sites to a DNA segment of choice, often generated by PCR or as synthetic DNA, allows recognition by
the BP ClonaseTM and recombination into a donor vector (pDONR) containing attP sites, yielding an entry clone (pENTR) carrying attL sites. The DNA
segment in the pENTR clone can then be transferred to a destination vector (pDEST) by recombination between attL and attR sites present on the pDEST
vector mediated by the LR ClonaseTM. This yields an expression clone (pEXP) in which the DNA segment again becomes flanked by attB sites. Positive
selection of pENTR and pEXP clones on medium containing appropriate antibiotics together with negative selection of starting products and by-products
(shown in grey) based on the presence of a negative (ccdB) selection marker between the recombination sites (GatewayTM Cassette) further increases the
efficiency of the system. (B) A combination of existing pENTRs, or new pENTRs, are easily assembled in a single MultiSite GatewayTM reaction catalyzed by
the LR II ClonaseTM Plus using pMG as destination vector. (C) Schematic representation of the MultiSite GatewayTM compatible vector set (pMG) for
transformation of S. cerevisiae. GOI, POI and TOI indicate gene, promoter and tag of interest, respectively. CmR, AmpR and KmR indicate chloramphenicol,
ampicillin and kanamycin resistance, respectively. B1-B4, P1-P2, L1-L4 and R1-R4 stand for the respective att sites. CycT indicates the CYC1 terminator on
the vector’s backbone.
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http://www.biomedcentral.com/1471-2199/13/30the integration of the phage’s DNA into the Escherichia
coli chromosome [4]. DNA segments that are flanked by
the appropriate recombination sites in a standard vector
(pENTR) can easily be transferred to a compatible vec-
tor (pDEST) for functional analysis (Figure 1A). Multi-
Site GatewayTM uses modified recombination sites to
allow the combination of multiple DNA segments in
one single in vitro recombination reaction. The seg-
ments are joined in a pDEST in a predefined order andorientation, maintaining the reading frame and with low
risk for mutations [4] (Figure 1B). Three-segment Multi-
Site GatewayTM makes it possible to easily make any
combination of a promoter, gene and tag without the
need of redesigning new destination vectors for each
new experimental approach. The ability to choose a pro-
moter allows varying temporal, spatial, and quantitative
control of gene expression, while different possible tags
enable the inclusion of fluorescent protein tags for
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Figure 2 Flexibility of the MultiSite Gateway™ cloning system. The flexibility of the MultiSite GatewayTM system is illustrated by the ample
possibilities to combine any gene of interest (GOI) with any promoter of interest (POI) and tag of interest (TOI), depending on the experimental needs.
Many of such sequences, including whole ORFeomes (cloned without STOP codon) of several model organisms [16-19] and a broad range of tags [5,9-11]
are already available in suitable pDONR vectors. L1-L4 and R1-R2 stand for the att sites attL1-attL4 and attR1-attR2, respectively. Asterisks mark constructs
generated in this study, lower case letters indicate constructs generated previously by others: a [8], b [30], c [19], d [16], e [5], f [9], g [10],h [11].
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or the creation of protein chimeras (Figure 2). The flexi-
bility introduced by the MultiSite GatewayTM technology
is illustrated by the large amount of “building blocks”
already made available as pENTR clones by several re-
search groups [5-11]. Existing pENTR collections in-
clude ORFeomes from multiple prokaryotic and
eukaryotic organisms [12-26].
Single-segment pDEST vectors are available for vir-
tually all commonly used systems, such as Drosophila
[27]. Moreover, for plants an extensive repertoire of
pDEST for two- and three-segment MultiSite GatewayTM
has been established [28]. Three-segment MultiSite
GatewayTM destination vectors are also available for
Gram-positive bacteria [29]. In S. cerevisiae, single-
segment pDEST vectors are available for yeast two-hybrid
screens (Invitrogen), and two-segment (promoter::ORF)
MultiSite GatewayTM vectors have been described [30].
An extensive set of single-fragment GatewayTM vectors
was constructed, allowing N-terminal fusions with four
fluorescent tags, and C-terminal fusions with five differ-
ent fluorescent tags, an affinity tag and an epitope tag
under the control of the inducible GAL1 or constitutive
GPD promoter [31]. Alternatively, tags that are not
present in this vector set can be fused to the gene of
interest through 2-step PCR fusion [32] before perform-
ing the BP reaction. However, to our knowledge no
three-segment MultiSite GatewayTM pDEST vectors exist
for S. cerevisiae to date. As a consequence, a large num-
ber of commonly used protein tags already available aspENTR clones are not readily applicable in the organism
that - together with E. coli - is the workhorse of molecu-
lar biology.
In this paper we present a set of eleven functionally
validated three-segment MultiSite GatewayTM pDEST
vectors for use in S. cerevisiae. The vector set features
the four most commonly used auxotrophic markers for
selection of yeast transformants combined with three
different replication mechanisms. The presence of the
CYC1 terminator in these vectors allows construction of
any promoter::ORF:tag combination. In addition, a num-
ber of useful entry clones harbouring commonly used
yeast promoters and entry clones with protein tags to be
used with these pDESTs are presented and validated.
These vectors have been appended to our collection of
‘Gateway™ vectors for functional studies’ and can be or-
dered through the website http://gateway.psb.ugent.be/.
Finally, we illustrate the applicability of this vector set
by confirming the formation of a ternary complex be-
tween the jasmonate ZIM-domain (JAZ), the Novel
Interactor of JAZ (NINJA) and the TOPLESS (TPL)
proteins, with NINJA acting as a bridging protein.
This complex was previously shown to be involved in
jasmonate signalling in the model plant Arabidopsis
(Arabidopsis thaliana) [33].
Results and discussion
Construction of MultiSite GatewayTM vectors
The MultiSite GatewayTM cassette of pKm43GW
(http://gateway.psb.ugent.be/) flanked by attB4 and
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striction sites (Additional file 1). The amplification prod-
uct was subsequently cloned into the XhoI and SacI sites
present in the backbones of the vectors of the pAG-
series [31]. This step replaced the original GatewayTM
cassette and the eukaryotic promoter from the pAG vec-
tors, while maintaining the CYC1 terminator. Ligation
products were transformed into ccdB resistant E. coli
cells (One shot ccdB survivalTM, Invitrogen). The pAG
vectors contain an ampicillin resistance gene for selec-
tion in E. coli, one of four different auxotrophic selection
markers (HIS3, LEU2, TRP1, and URA3) and one of
three different replication determinants (2 μ ori, CEN,
or Integrating) thus giving rise to a MultiSite GatewayTM
vector set (Figure 1C) for expression in S. cerevisiae (see
Table 1 for nomenclature). We did not succeed in creat-
ing the Integrating vector with the HIS3 autotrophic
marker (Table 1).
Testing the versatility of the system
To illustrate the flexibility of this vector collection, we
took advantage of a few “building blocks” for MultiSite
GatewayTM cloning that were available in-house as entry
clones (Figure 2, http://gateway.psb.ugent.be/). One of
the assets of MultiSite GatewayTM destination vectors is
that any promoter of interest can be used, provided it is
available as an entry clone flanked by attL4 and attR1
sites. To achieve this, we cloned two constitutively active
promoters (pGPD/TDH3 and pADH1) and a galactose-
inducible promoter (pGAL1) into pDONR P4-P1R (Invi-
trogen). The inducibility of the GAL1 promoter was
verified by expression in yeast of a heterologous Arabi-
dopsis gene fused to a NLS-FLAG-HIS tag under theTable 1 Nomenclature of the S. cerevisiae MultiSite
GatewayTM pDEST vectors
Name* Replication Selectable marker
pMG304 Integrating TRP1
pMG305 Integrating LEU2
pMG306 Integrating URA3
pMG413 CEN HIS3
pMG414 CEN TRP1
pMG415 CEN LEU2
pMG416 CEN URA3
pMG423 2 μ HIS3
pMG424 2 μ TRP1
pMG425 2 μ LEU2
pMG426 2 μ URA3
*pMGXYZ where MG indicates the presence of the MultiSite GatewayTM
cassette; X stands for the presence (4) or absence (3) of replication
determinants on the vector; Y stands for the replication determinant:
Integrating (0), CEN (1) or 2 μ (2); Z indicates the auxotrophic selection marker:
HIS3 (3), TRP1 (4), LEU2 (5) or URA3 (6).control of the GAL1 promoter using pMG416
(Figure 3A).
Another advantage of the MultiSite GatewayTM system
is that several different tag sequences are readily avail-
able (Figure 2) and can easily be introduced to acquire
translational fusions, since the att sites do not disturb
the reading frame. For proof-of-concept, we cloned dif-
ferent plant genes (without STOP codon) in a C-
terminal translational fusion with either a V5, c-myc, or
FLAG-HIS tag. To make these constructs compatible
with protein interaction studies in yeast, we additionally
fused each epitope tag with a nuclear localization signal
(NLS) derived from SV40, thereby creating the NLS-
3xV5, NLS-3xc-myc, and NLS-3xFLAG-6xHIS tags, re-
spectively. Such constructs allow avoiding false negative
experimental outcomes that result from protein localisa-
tion in different cellular compartments, for instance.
Tagged plant proteins were expressed in yeast under the
control of the constitutive GPD or ADH1 promoters in
different vectors from our set. Total protein extracts
were obtained and the expressed proteins were visua-
lized through immunoblot analysis (Figure 3B). The
(NLS)FLAG-HIS tag is particularly suitable when protein
purification under denaturing conditions is needed,
while, at the same time, low background detection on
immunoblots is desired.
To express C-terminal translational fusions by means
of our promoters, tags and destination vectors, entry
vectors containing the GOI should be cloned with a start
codon and without a stop codon, and the manufacturer’s
guidelines regarding the reading frame should be
adopted (http://www.invitrogen.com). Organisms for
which ORFeome collections contain vectors that match
these criteria include several bacterial collections
(Brucella melitensis [12], Pseudomonas aeruginosa [13],
Bacillus anthracis, Francisella tularensis, Helicobacter
pylori, Mycobacterium tuberculosis, Rickettsia prowaze-
kii, Staphylococcus aureus, Streptococcus pneumoniae,
Vibrio cholerae [14]), human and mouse [15], plants
(Arabidopsis [16], maize, sorghum, sugarcane, rice [17]),
viruses [18] and yeasts (S. cerevisiae [19] and Schizosac-
charomyces pombe [20]). Caution is advised since some
ORFeome collections contain entry clones both with
and without stop codon [15,16]. ORFeome collections
that comprise only GOI’s provided with a stop codon, as
is the case for some bacterial and viral ORFeomes
(Neisseria gonorrhoeae [21], Sinorhizobium meliloti [22],
Yersinia pestis [14], and Hepatitis C [23]) are not com-
patible with our vectors. Other ORFeomes in which the
GOI is cloned without a start and without a stop codon
(Caenorhabditis elegans [24,25], E. coli [26]), are not
compatible with our current promoters but can be used
for expression of C-terminal translational fusions with
our vectors provided the promoter is cloned followed by
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Figure 3 Versatility of the newly generated MultiSite GatewayTM vector set. (A) Inducibility of the pGAL1 promoter. Arabidopsis genes
At4g32295 and At3g24150 were expressed in yeast under the control of the pGAL1 promoter and fused with an NLS-FLAG-HIS tag using the pMG416
vector. After total protein extraction, expression was verified in inducing (+) and non-inducing (−) medium through immunoblot analysis with anti-FLAG
antibodies. (B) Functionality of newly developed C-terminal translational fusion epitope tags. Yeasts were transformed with pMG425-ADH1::JAZ12:−NLS-
FLAG-HIS, pMG423-GPD::COI1-C:−NLS-V5 where COI1-C is a truncated version of COI1, or pMG423-GPD::At2g26000: NLS-c-myc. Expression of the different
constructs was verified with immunoblot analysis of total protein extracts with anti-FLAG, anti-V5 and anti-c-myc antibodies, respectively. (C) Interaction of
proteins in the trimeric JAZ3-TPL-NINJA complex in Y3H assays. Transformed yeasts were spotted in 10-fold and 100-fold dilutions on control medium (−3:
SD-Leu-Trp-Ura) and selective medium (−4: SD-His-Leu-Trp-Ura). Gene constructs in the pGBKT7 and pGADT7 vectors carry the DNA-binding domain or
the transcription activation domain, respectively, in contrast to constructs expressed in pMG426, which do not carry DNA-binding or transcription
activation domains. (D) Verification of expression of NINJA: NLS-FLAG-HIS in the Y3H set-ups shown in panel C. After total protein extraction, NINJA: NLS-
FLAG-HIS was detected through immunoblot analysis with anti-FLAG antibodies. Arrowheads indicate the fusion protein.
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and, as described above, different approaches are used
when cloning the GOI, the compatibility of available
pENTR collections should always be corroborated either
in silico before assembling the different sequences into
expression vectors or through epitope tag detection in
immunoblots. Finally, the destination vector set pre-
sented here also allows expression of N-terminal fusions,
provided the att sites flanking the different fusion com-
ponents are adapted accordingly.
Value of the vector set
The value of this vector set was exemplified by a yeast
three-hybrid (Y3H) experiment, in which we investigated
the formation of the ternary protein complex by the
Arabidopsis JAZ3, NINJA, and TPL proteins. We have
proposed recently that the adaptor protein NINJA
bridges the JAZ proteins to TPL proteins and thereby
forms a repressor complex that blocks the cellular pro-
grams regulated by the jasmonates, ubiquitous plant
hormones that regulate various aspects of plant growth,
development, and survival [33]. TPL interacts with theETHYLENE RESPONSIVE FACTOR–associated amphi-
philic repression (EAR) motif that is present in NINJA
[33] but absent in most JAZ proteins, including JAZ3.
Some JAZ proteins however, i.e. JAZ5 to JAZ8, contain
EAR motifs themselves and are capable of direct inter-
action with TPL [34-36].
The N-terminal domain of TPL contains the LisE and
CTHL domains and was previously shown to be essen-
tial for binding the EAR motif in Aux/IAA proteins [37].
Therefore we cloned this part (denominated TPL-N) as
a bait protein for Y2H. In agreement with the proposed
models, the interaction of TPL-N with NINJA was con-
firmed but TPL-N could not interact with JAZ3
(Figure 3C).
Commonly used Y2H vectors such as pGADT7 and
pGBKT7 (Clontech) are designed such that the bait and
prey fusion proteins are targeted to the same subcellular
compartment (i.e. nucleus) and are equipped with an
epitope tag, HA and c-myc, respectively, allowing easy
confirmation of expression through immunoblot. To
verify whether NINJA can connect EAR-lacking JAZs
with TPL, as previously proposed [33], we performed a
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of a constitutive promoter (pGPD), as a bridging protein.
Hereby we used the MultiSite GatewayTM vector
pMG426 (Table 1) that carries the URA3 auxotrophic
marker that is often still available in yeast strains used
for Y2H. As a C-terminal tag we used the NLS-FLAG-
HIS tag. Only when NINJA is co-expressed, yeast growth
was observed on selective –His medium, indicating that
interaction between JAZ3 and TPL requires the involve-
ment of NINJA (Figure 3C-D).
Conclusions
We have successfully constructed a set of three-segment
MultiSite GatewayTM destination vectors for S. cerevi-
siae. Our findings make high-throughput recombinator-
ial cloning of multiple genetic segments in one single
reaction accessible in one of the most widely used ex-
perimental model systems in molecular biology. The
availability of different auxotrophic markers in this vec-
tor set, together with the large amount of existing com-
patible building blocks for MultiSite GatewayTM cloning
already available in several research groups, creates a
versatile utility for these vectors. In addition, we have
cloned two constitutive and one inducible yeast pro-
moter in appropriate pENTR vectors and constructed
three novel epitope tags, each including a NLS, which
are suitable for interaction studies in yeast.
The usefulness of the MultiSite GatewayTM vectors
was demonstrated in a Y3H assay with which we corro-
borated the hypothesis that NINJA connects the JAZ
proteins with the co-repressor TPL. This trimeric com-
plex mediates repression of jasmonate responsive genes
in the absence of the hormone [33].
Implementation of the vector set presented in this art-
icle, together with the cloning of more promoters and
(epitope) tags according to personal experimental needs,
will facilitate gene functional studies and contribute to
the high-throughput versatile expression of heterologous
(plant) proteins in yeast.
Methods
Strains and growth conditions
The E. coli strains used were either the ccdB resistant
strain DB3.1 (Invitrogen) or the ccdB sensitive strain
DH5α. Both were grown at 37°C in LB broth medium
with appropriate antibiotics. Several different commonly
used yeast lab-strains were grown at 30°C in synthetic
defined medium (Clontech) lacking the appropriate
amino acids.
MultiSite GatewayTM cloning and yeast transformation
MultiSite LR reactions were performed in 10 μL total
volume containing 10 fmoles of each entry vector, 20
fmoles of destination vector, and 2 μL LR II ClonaseTMPlus (Invitrogen). The reaction was incubated overnight
at 25°C. After proteinase treatment, the mix was trans-
formed into E. coli DH5α. Colonies that grew on select-
ive medium were picked and the insert was sequenced
using M13 forward and reverse primers (Additional file 1).
To maintain the reading frame, necessary for expression of
translational fusions, MultiSite GatewayTM cloning was car-
ried out according to the manufacturer’s guidelines (http://
www.invitrogen.com). Note that in order to produce
C-terminal translational fusions, the ORFs used should be
without STOP codon. A convenient method to obtain sim-
ultaneously clones of ORFs with and without STOP codon
has been described [38].
Competent yeast cells were transformed using the
LiAc/SS carrier DNA/PEG method [39].
Promoter cloning
The attB4 and attB1 sites were introduced in the pri-
mers used for promoter amplification (Additional file 1).
A PCR was performed using Phusion High-Fidelity PCR
Kit (Thermo Fisher Scientific) on 50 ng of pBEVY-A,
pBEVY-GL [40], and pGAD424 (Clontech) as template
for the GPD, GAL, and ADH1 promoters, respectively.
PCR products were purified with the GeneJET Gel Ex-
traction kit (Fermentas). BP reactions were performed in
a total volume of 5 μl containing 1 μl enzyme, 300 ng
pDONR P4-P1R (Invitrogen), and 30 ng of PCR product.
Incubation and subsequent treatments were the same as
those for MultiSite LR reactions.
Epitope-tag design and immunoblot analysis
Synthetic DNA encoding NLS-3xFLAG-6xHIS, NLS-
3xV5, and NLS-3xc-myc flanked by attB2R-attB3 sites
were designed in Vector NTIW (Invitrogen) and ordered
from GenScript as clones in the pUC57 vector. These
tags were introduced into pDONR P2R-P3 through a BP
reaction. The resulting entry vectors were transformed
into E. coli and sequence verified.
Total yeast protein extracts were obtained as described
[41] and concentration quantified using the Bio-Rad
Protein Assay (Bio-Rad). Samples were combined with
5x Laemmli loading buffer and denatured for 10 min at
95°C. Subsequently, 30 μg total protein was loaded on a
4–15% Mini-PROTEANW TGX™ Precast Gel (Bio-Rad)
and transferred to a PVDF membrane using the Trans-
Blot Turbo transfer system (Bio-Rad). Detection was
performed using the following primary antibodies: anti-
FLAG (Sigma), anti-c-myc-HRP (Invitrogen), anti-HA
(Roche), and anti-V5 (Sigma).
Yeast two- and three-hybrid
The primers were designed to clone the ORF corre-
sponding to TPL-N with and without STOP codon
(Additional file 1) [38]. The entry clones pEN-L4-GPD-
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L2 were recombined by MultiSite GatewayTM LR reaction
with pMG426 as destination vector. Construction of the
pGADT7- and pGBKT7-clones, and the Y2H and Y3H were
carried out as described [33] except that transformed yeast
cells (strain PJ69-4a) were selected on SD-Ura-Trp-Leu.
Additional file
Additional file 1: Primers used and their sequence.
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